Neoadjuvant Therapy

Known as: Neoadjuvant Treatments, Treatments, Neoadjuvant, Induction Therapy 
Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy… (More)
National Institutes of Health

Related topics

Related topics

2 relations
nursing therapystandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
This is a pre-copyedited, author-produced version of an article accepted for publication in Annals of Oncology, following peer… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2017
Review
2017
HER2-positive breast cancer
Anti-HER2 treatment for HER2-positive breast cancer has changed the natural biology of this disease. This Series article reviews… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2017
Review
2017
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
PURPOSE We systematically review the benefits and harms of intravesical therapies for nonmuscle invasive bladder cancer… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
PURPOSE The exact definition of pathologic complete response (pCR) and its prognostic impact on survival in intrinsic breast… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
BACKGROUND In a previous meta-analysis, we identified a survival benefit from neoadjuvant chemotherapy or chemoradiotherapy… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth…
PURPOSE The objective of this study was to determine whether the addition of trastuzumab to chemotherapy in the neoadjuvant… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
BACKGROUND Despite aggressive local therapy, patients with locally advanced bladder cancer are at significant risk for metastases… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.
PURPOSE To define prognostic factors for response and long-term outcome for a wide spectrum of osteosarcomas, extending well… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized…
PURPOSE Expression of ErbB-1 and ErbB-2 (epidermal growth factor receptor and HER2/neu) in breast cancer may cause tamoxifen… (More)
Is this relevant?